High Plasma Levels of Heparin-Binding Epidermal Growth Factor Are Associated With a More Stable Plaque Phenotype and Reduced Incidence of Coronary Events.

Sara Rattik, Maria Wigren, Harry Björkbacka, Gunilla Nordin Fredrikson, Bo Hedblad, Agneta Siegbahn, Eva Bengtsson, Alexandru Schiopu, Andreas Edsfeldt, Pontus Dunér, Helena Grufman, Isabel Goncalves, Jan Nilsson

Research output: Contribution to journalArticlepeer-review

Abstract

Rupture of atherosclerotic plaques is the major cause of acute coronary events (CEs). Plaque destabilization is the consequence of an imbalance between inflammatory-driven degradation of fibrous tissue and smooth muscle cell-dependent tissue repair. Proinflammatory factors have been documented extensively as biomarkers of cardiovascular risk but factors that contribute to stabilization of atherosclerotic plaques have received less attention. The present study aimed to investigate whether plasma levels of the smooth muscle cell growth factor epidermal growth factor (EGF), heparin-binding-EGF (HB-EGF), and platelet-derived growth factor correlate with plaque phenotype and incidence of CEs.
Original languageEnglish
Pages (from-to)222-228
JournalArteriosclerosis, Thrombosis and Vascular Biology
Volume35
Issue number1
DOIs
Publication statusPublished - 2015

Subject classification (UKÄ)

  • Cardiology and Cardiovascular Disease

Fingerprint

Dive into the research topics of 'High Plasma Levels of Heparin-Binding Epidermal Growth Factor Are Associated With a More Stable Plaque Phenotype and Reduced Incidence of Coronary Events.'. Together they form a unique fingerprint.

Cite this